[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].

MLA

Ikeda, Masahiko, et al. “[A Case of HER2 Overexpressing Advanced Breast Cancer with CTF Therapy [Cyclophosphamide, Pirarubicin (THPADM), Fluorouracil] Showed Long-Term Effectiveness after Paclitaxel Shock].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 37, no. 13, Dec. 2010, pp. 2917–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21160270&authtype=sso&custid=ns315887.

APA

Ikeda, M., Sonoo, H., Oota, Y., Fujii, S., Shimo, T., Miyake, A., Seki, M., Nomura, T., Yamamoto, Y., Shiiki, S., Nakashima, K., Tanaka, K., & Kurebayashi, J. (2010). [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 37(13), 2917–2920.

Chicago

Ikeda, Masahiko, Hiroshi Sonoo, Yusuke Oota, Sayaka Fujii, Toshirou Shimo, Akiko Miyake, Mari Seki, et al. 2010. “[A Case of HER2 Overexpressing Advanced Breast Cancer with CTF Therapy [Cyclophosphamide, Pirarubicin (THPADM), Fluorouracil] Showed Long-Term Effectiveness after Paclitaxel Shock].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 37 (13): 2917–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21160270&authtype=sso&custid=ns315887.